MGTX - MeiraGTx Holdings plc Ordinary Shares

Day 1m 10m 60m PreMarket Market AfterHours Gap
8.03 0.11 (1.37%) --- --- --- --- 0.11 (1.37%) --- ---

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.48
Diluted EPS:
-0.48
Basic P/E:
-16.9583
Diluted P/E:
-16.9583
RSI(14) 1m:
73.65
VWAP:
8.12
RVol:
0.5652

Events

Period Kind Movement Occurred At
1m Price increase 1m 8.22 +0.1 (+1.17%) Oct 15 10:48

Related News